Arovella Therapeutics Ltd
ASX:ALA

Watchlist Manager
Arovella Therapeutics Ltd Logo
Arovella Therapeutics Ltd
ASX:ALA
Watchlist
Price: 0.088 AUD 1.15% Market Closed
Market Cap: 104.2m AUD

Intrinsic Value

ALA doesn't have a meaningful market cap.

The intrinsic value of one ALA stock under the Base Case scenario is 0.006 AUD. Compared to the current market price of 0.088 AUD, Arovella Therapeutics Ltd is Overvalued by 93%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ALA Intrinsic Value
0.006 AUD
Overvaluation 93%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Arovella Therapeutics Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
ALA
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for ALA cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

No research report yet

Want a deep‑dive on Arovella Therapeutics Ltd?
Request it below and we’ll move it up the queue.

Request This Report
What’s Inside the Report:
Whether it’s a smart buy right now
If the stock is undervalued
Its long-term growth potential
Whether the dividend is safe
How it compares to peers
How strong its moat is
Whether management can be trusted
You Can Read These Reports Right Now
Dive in while we’re working on Arovella Therapeutics Ltd’s research
View All Researches
Arovella Therapeutics Ltd
ASX:ALA
AU
Pharmaceuticals
Market Cap
104.2m AUD
IPO
Jan 24, 2002
AU
Pharmaceuticals
Market Cap
104.2m AUD
IPO
Jan 24, 2002
Price
AU$false
EPS
AU$false
AI Assistant
AI Assistant
Ask me anything about Arovella Therapeutics Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Arovella Therapeutics Ltd

Current Assets 12.2m
Cash & Short-Term Investments 11.8m
Other Current Assets 455.3k
Non-Current Assets 441.3k
PP&E 441.3k
Efficiency

Free Cash Flow Analysis
Arovella Therapeutics Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Arovella Therapeutics Ltd

Revenue
442.1k AUD
Operating Expenses
-6.7m AUD
Operating Income
-6.3m AUD
Other Expenses
0 AUD
Net Income
-6.3m AUD
Fundamental Scores

ALA Profitability Score
Profitability Due Diligence

Arovella Therapeutics Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Exceptional 3-Years Revenue Growth
Exceptional ROIC
Exceptional 1-Year Revenue Growth
50/100
Profitability
Score

Arovella Therapeutics Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

ALA Solvency Score
Solvency Due Diligence

Arovella Therapeutics Ltd's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

Arovella Therapeutics Ltd's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ALA Price Targets Summary
Arovella Therapeutics Ltd

There are no price targets for ALA.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Arovella Therapeutics Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for ALA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

ALA Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one ALA stock?

The intrinsic value of one ALA stock under the Base Case scenario is 0.006 AUD.

Is ALA stock undervalued or overvalued?

Compared to the current market price of 0.088 AUD, Arovella Therapeutics Ltd is Overvalued by 93%.

Back to Top